BRIEF published on 04/28/2026 at 20:40, 10 days 23 hours ago GenSight Biologics annonce son Assemblée Générale Mixte de 2026 Actionnaires Assemblée Générale Documents Préparatoires Thérapie Génique GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 10 days 23 hours ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
BRIEF published on 04/28/2026 at 20:40, 10 days 23 hours ago GenSight Biologics programme son assemblée générale annuelle pour mai 2026 Conformité Réglementaire Assemblée Générale Annuelle Thérapie Génique Relations Avec Les Investisseurs Informations Destinées Aux Actionnaires
BRIEF published on 04/28/2026 at 20:40, 10 days 23 hours ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
PRESS RELEASE published on 04/28/2026 at 20:35, 10 days 23 hours ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 19, 2026, in Paris. Shareholders can access preparatory documents online. Meeting details and documents available on company website Annual General Meeting Shareholders Preparatory Documents Meeting Details GenSight Biologics
PRESS RELEASE published on 04/28/2026 at 20:35, 10 days 23 hours ago Informations privilégiées / Autres communiqués GenSight Biologics annonce sa prochaine Assemblée Générale Mixte du 19 mai 2026 avec mise à disposition des documents préparatoires. Informations complètes disponibles sur le site de la Société Documents Préparatoires Assemblée Générale Mixte GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
BRIEF published on 04/07/2026 at 19:04, 1 month 2 days ago GenSight Biologics : Bilan financier et avancées sur l'AAC Trésorerie Levée De Fonds Thérapie Génique GenSight Biologics Accès Compassionnel
BRIEF published on 04/07/2026 at 19:04, 1 month 2 days ago GenSight Biologics fait le point sur sa trésorerie et ses revenus liés à l'accès anticipé. Thérapie Génique GenSight Biologics Revenu Programme D'accès Anticipé Position De Trésorerie
BRIEF published on 04/07/2026 at 19:04, 1 month 2 days ago GenSight Biologics: Financial Update and Progress on AAC Fundraising Treasury Gene Therapy GenSight Biologics Compassionate Access
BRIEF published on 04/07/2026 at 19:04, 1 month 2 days ago GenSight Biologics Reports Cash Status and Early Access Revenues Revenue Cash Position Gene Therapy GenSight Biologics Early Access Program
Published on 05/09/2026 at 01:30, 18 hours 37 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 20 hours 7 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 1 hour 2 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 23 hours 29 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 1 hour ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 1 hour ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 1 hour ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 1 hour ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
